Common Contracts
4 similar Terms Agreement contracts by Angion Biomedica Corp., Biospecifics Technologies Corp, ImmunityBio, Inc., Viking Therapeutics, Inc.
ANGION BIOMEDICA CORP. Common Stock ($0.01 par value per share) AT-THE-MARKET EQUITY OFFERING SALES AGREEMENTTerms Agreement • May 16th, 2022 • Angion Biomedica Corp. • Pharmaceutical preparations • New York
OPEN MARKET SALE AGREEMENTSMTerms Agreement • May 3rd, 2021 • ImmunityBio, Inc. • Biological products, (no disgnostic substances) • New York
Reference is made to that certain Open Market Sale Agreement, dated as of April 30, 2021 (the “Agreement”) by and between ImmunityBio, Inc., a Delaware corporation (the “Company”), and Jefferies LLC. Capitalized terms used without definition herein shall have the meanings assigned thereto in the Agreement.
BIOSPECIFICS TECHNOLOGIES CORP. Common Stock ($0.001 par value per share) AT- THE-MARKET EQUITY OFFERING SALES AGREEMENTTerms Agreement • August 31st, 2020 • Biospecifics Technologies Corp • Pharmaceutical preparations • New York
AT-THE-MARKET EQUITY OFFERING SALES AGREEMENTTerms Agreement • August 2nd, 2019 • Viking Therapeutics, Inc. • Pharmaceutical preparations • New York
